Navigation Links
Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
Date:1/7/2009

our products directly to the end user.


    Summary of Instrument Orders

                                     Q2 2009 Orders            Cumulative
    Instrument               N.A.(1)       ROW(2)     Total     Orders(3)
    Echo                       31            21        52          430
    Galileo                     1            15        16          602


    (1) N.A. - North America (the U.S. and Canada)
    (2) ROW - all parts of the world other than North America.

(3) Cumulative Orders - total orders received since the launch of the instrument.

"On a year-to-date basis, we have received 176 Echo orders, which demonstrates the tremendous market acceptance of our instrument," stated Dr. De Chirico. "Of the cumulative 430 Echo orders, approximately 193 were generating reagent revenue, which is an increase of 64 instruments in the quarter."

Raising 2009 EPS Guidance

The Company continues to expect revenue for the fiscal year ending May 31, 2009, to range from $292 million to $300 million, unchanged from the Company's previous estimate. Gross margin is now expected to be in the range of 71.0% to 73.0%, compared with the Company's previous guidance of 70.0% to 71.0%. Fully diluted earnings per share are now expected to be in the range of $0.97 to $1.02 for the fiscal year, compared with the Company's previous estimate of $0.94 to $0.98.

"In summary, our business is doing well in this troubled economic environment because of our strong product offering as well as our strong balance sheet and cash flow," stated Dr. De Chirico. "I am pleased with our projected performance for the remainder of fiscal 2009."

Conference Call

Immucor, Inc. will host a conference call Thursday, January 8, 2009 at 8:30 AM (Eastern Time) to review these results. Investors are invited to participate in this conference call with Dr. Gioacchino
'/>"/>

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Immucor Schedules First Quarter Earnings Release and Conference Call
2. Immucor Announces Record Fiscal First Quarter Revenues
3. Immucor, Inc. Appoints New Chief Financial Officer
4. Immucor Announces Update to Second Quarter Conference Call Number
5. Immucor, Inc. Adds Director to Board
6. Immucor Schedules Third Quarter Earnings Release and Conference Call
7. Immucor Announces Record Fiscal Third Quarter Results
8. Immucor Responding to FDA Warning Letter
9. Immucor Schedules Fiscal 2009 Guidance Call
10. Immucor Closes BioArray Acquisition
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 For survivors of severe combat injuries threatening ... flaps have a good record of safety and effectiveness ... issue of Plastic and Reconstructive Surgery ... Society of Plastic Surgeons (ASPS). , Experience with ... and Afghanistan shows good success rates, with no increase ...
(Date:7/29/2014)... By Randy Dotinga ... (HealthDay News) -- When most children take on a ... less of this neuro-boosting activity in kids with autism, ... with more severe symptoms of autism displayed even less ... ,"This reduced flexibility often causes difficulty when children ...
(Date:7/29/2014)... (HealthDay News) -- Although the bite of a brown ... if left alone, an expert notes. It,s still ... reaction to a brown recluse spider bite, warned Dr. ... particularly since these potentially dangerous bites are on the ... to do nothing. The [bite] has classic characteristics, but ...
(Date:7/29/2014)... Angeles, CA (PRWEB) July 29, 2014 ... the website of Time Magazine titled “From Kim’s Butt ... Kim Kardashian’s butt is the celebrity feature ... and their features include Beyoncé’s butt, Jennifer Lawrence’s ... lips. This information is based on data collected by ...
(Date:7/29/2014)... (July 29, 2014) Using quality improvement measures in ... England Cardiovascular Disease Study Group, researchers have found a ... procedure with contrast dye. , Currently, 7-15 percent of ... contrast-dye end up with kidney injury, which can result ... to temporary or permanent dialysis, says a study published ...
Breaking Medicine News(10 mins):Health News:Good outcomes with multiple limb salvage after severe combat injuries, reports Plastic and Reconstructive Surgery 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 3Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Celebrity Plastic Surgery: Kim Kardashian’s Butt Tops the List of Celebrity Plastic Surgery Requests 2Health News:Reducing kidney injury using a quality improvement method 2
... Disease are more likely to display abnormal social behaviour ... are pathological gamblers, according to research in the January ... A number of studies have already associated pathological ... impulse control disorder associated mainly with dopamine replacement therapy. ...
... which have no tangible existence, arise out of physical ... Institute of Science provided evidence, for the first time, ... experience of seeing. In research recently published in ... research student Lior Fisch of the Weizmann Institute,s Neurobiology ...
... simple and inexpensive eye test could aid detection and diagnosis ... stage than is currently possible, according to new research by ... & Stephen Moss and published today in Cell Death ... and therefore brain cell death, to be directly measured in ...
... ... ... SonRidge, LLC, a catering and chef supplies company located in Western Massachusetts, found themselves in ... industry. What they discovered was an innovative resolution that not only solved an issue for ...
... , , EUGENE, Ore. , ... group gaining national recognition for its unprecedented work, has released ... Preventing HIV/AIDS for Women with Intellectual Disabilities. , With AIDS ... 25 - 44 in the United States , this ...
... ... DRE Velocity EKG, a portable PC-based EKG/ECG system that provides powerful data and analysis functions. ... (Vocus) January 14, 2010 ... —offers the DRE Velocity EKG , a 12-channel PC-based EKG system that provides impressive ...
Cached Medicine News:Health News:Parkinson's patients who are pathological gamblers also display abnormal social behavior 2Health News:To see or not to see 2Health News:Seeing a diagnosis: How an eye test could aid Alzheimer's detection 2Health News:Insulated Transport Containers Go Green 2Health News:The Tech-Aid Institute Releases HIV/AIDS Prevention Software for Women with Intellectual Disabilities 2Health News:Cost-effective PC-based EKG Now Available from DRE 2Health News:Cost-effective PC-based EKG Now Available from DRE 3
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)...  Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical ... unmet needs in oncology, autoimmune and inflammatory disease, today ... closing of the NASDAQ Global Market on Tuesday, August ... by Michael Martino , president and CEO, and ... the same day at 5:00 pm EDT (2:00 pm ...
(Date:7/29/2014)... July 29, 2014   Abide Therapeutics ... to its board of directors. Thornberry was ... and Endocrinology for Merck & Co. Inc., where ... pipeline management in diabetes, osteoporosis, fertility and contraception. ... the program that resulted in the discovery of ...
Breaking Medicine Technology:Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3
... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
ELISA for detection of Anti-Gliadin IgA....
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Enzyme immunoassay for the quantitative determination of Gliadin-IgA antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
Medicine Products: